Code | CSB-RA959292A0HU |
Size | US$210 |
Order now | |
Image |
|
Have Questions? | Leave a Message or Start an on-line Chat |
Application | Recommended Dilution |
---|---|
WB | 1:500-1:2000 |
IHC | 1:50-1:200 |
The production of the OS9 recombinant monoclonal antibody follows a meticulous and standardized process to ensure its quality and specificity. Initially, B cells are isolated from an immunized animal, with the synthesized peptide derived from human OS9 used as the immunogen. Total RNA is extracted from the B cells and converted into cDNA through reverse transcription. The OS9 antibody genes are then amplified using PCR with primers specific to the antibody constant regions and inserted into an expression vector. The vector is introduced into host cells, allowing for the production of the OS9 recombinant monoclonal antibody. After harvesting the antibody from the cell culture supernatant, it undergoes purification using affinity chromatography to obtain a highly purified form. Rigorous characterization assays, including ELISA, WB, and IHC analysis, are performed to validate the antibody's specificity and functionality, ensuring its precise binding to human and mouse OS9 protein. This meticulous production process ensures the generation of a reliable and effective OS9 recombinant monoclonal antibody, suitable for various applications in OS9-related research.
There are currently no reviews for this product.